secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK:        0001446847
Form:       8-K/A
Filed at:   2026-05-21T20:05:34+00:00
Accession:  0001104659-26-065140
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ironwood appoints Ronald Silver interim CFO; approves $12,250 monthly fee and 25,000 RSUs
--------------------------------------------------------------------------------

- Monthly interim assignment fee of $12,250 approved for interim CFO Silver effective May 19, 2026.
- Silver received 25,000 RSUs vesting 50% each anniversary over two years.
- Fee and RSUs remain until permanent CFO appointed or interim assignment ends.
- Silver also serves as SVP, Corporate Controller and Chief Accounting Officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446847/000110465926065140/0001104659-26-065140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446847/000110465926065140/tm2615121d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-065140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer